We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Reliance Gen. | LSE:GMX | London | Ordinary Share | GB00B1MM9925 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.55 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2020 to Jan 2025
TIDMGMX
RNS Number : 8502D
Reliance GeneMedix PLC
30 March 2011
Reliance GeneMedix plc
(the "Company")
(AIM: GMX)
Reliance GeneMedix plc, the AIM listed biopharmaceutical company, hereby provides an update to the news it released in its interim results announcement on 16 December 2010 that it had submitted an application to the European Medicine Agency ("EMA") for the authority to market its core product, Erythropoietin ("EPO"), in Europe. Based on its initial assessment of the application, EMA has asked for additional data to be provided by the Company which is expected to take more time than permitted by the EMA prescribed schedule.
As a consequence, the Company has decided to withdraw its application to EMA for the time being and is evaluating EMA's comments before developing a plan to generate that data by doing certain additional studies and to resubmit the application in due course.
In accordance with AIM Rule 26, a copy of this announcement is available on the Company's website at www.genemedix.com.
30 March 2011
ENQUIRIES:
Reliance GeneMedix plc Tel: +353 57 932 3572
Vinay Ranade, Chief Executive Officer
Deloitte Corporate Finance Tel: +44 (0)20 7936 3000
Jonathan Hinton, John Ball
Lothbury Financial Services Limited Tel: +44 (0)20 7868 2567
Michael Padley
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUKRVRANAOUAR
1 Year Reliance Genemedix Chart |
1 Month Reliance Genemedix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
